Drugs / actarit
actarit
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03660059 Background | Sep 2018 → Apr 2021 | rheumatoid arthritis | Astellas Pharma Inc | Completed | Met primary |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | actarit | “hydroxychloroquine, salazosulfapyridine, gold (injection or oral), D-penicillamine, lobenzarit, actarit, bucillamine and iguratimod.” NCT03660059 ↗ |
| Known as | (p-acetamidophenyl)acetic acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL1885632 ↗ |
| Known as | Mirabegron (m9) | ChEMBL registry synonym — accepted as the source's own label CHEMBL1885632 ↗ |
| Known as | NSC-170317 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1885632 ↗ |
| Known as | Orcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL1885632 ↗ |
| Known as | YM-340790 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1885632 ↗ |
| Modality | Small molecule | — CHEMBL1885632 ↗ |